![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
p53 and Tumor Suppression: It Takes a Network
Anthony M. Boutelle, Laura D. Attardi
Trends in Cell Biology (2021) Vol. 31, Iss. 4, pp. 298-310
Open Access | Times Cited: 225
Anthony M. Boutelle, Laura D. Attardi
Trends in Cell Biology (2021) Vol. 31, Iss. 4, pp. 298-310
Open Access | Times Cited: 225
Showing 1-25 of 225 citing articles:
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 425
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 425
p53 in ferroptosis regulation: the new weapon for the old guardian
Yanqing Liu, Wei Gu
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 895-910
Open Access | Times Cited: 314
Yanqing Liu, Wei Gu
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 895-910
Open Access | Times Cited: 314
iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4
Delin Chen, Bo Chu, Xin Yang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 227
Delin Chen, Bo Chu, Xin Yang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 227
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 199
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 199
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Xiaohua Chen, Taotao Zhang, Wei Su, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 171
Xiaohua Chen, Taotao Zhang, Wei Su, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 171
Mutant p53: it’s not all one and the same
Margaret C. Kennedy, Scott W. Lowe
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 983-987
Open Access | Times Cited: 110
Margaret C. Kennedy, Scott W. Lowe
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 983-987
Open Access | Times Cited: 110
Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis
Hiroki Kitakata, Jin Endo, Hidehiko Ikura, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1414-1414
Open Access | Times Cited: 90
Hiroki Kitakata, Jin Endo, Hidehiko Ikura, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1414-1414
Open Access | Times Cited: 90
Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?
Annabella F. Thomas, Gemma L. Kelly, Andreas Strasser
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 961-971
Open Access | Times Cited: 72
Annabella F. Thomas, Gemma L. Kelly, Andreas Strasser
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 961-971
Open Access | Times Cited: 72
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Bin Song, Ping Yang, Shuyu Zhang
Cancer Communications (2024) Vol. 44, Iss. 3, pp. 297-360
Open Access | Times Cited: 20
Bin Song, Ping Yang, Shuyu Zhang
Cancer Communications (2024) Vol. 44, Iss. 3, pp. 297-360
Open Access | Times Cited: 20
p53: A tale of complexity and context
Moshe Oren, Carol Prives
Cell (2024) Vol. 187, Iss. 7, pp. 1569-1573
Open Access | Times Cited: 15
Moshe Oren, Carol Prives
Cell (2024) Vol. 187, Iss. 7, pp. 1569-1573
Open Access | Times Cited: 15
Dose-effect of polystyrene microplastics on digestive toxicity in chickens (Gallus gallus): Multi-omics reveals critical role of gut-liver axis
Kai Yin, Dongxu Wang, Yue Zhang, et al.
Journal of Advanced Research (2022) Vol. 52, pp. 3-18
Open Access | Times Cited: 60
Kai Yin, Dongxu Wang, Yue Zhang, et al.
Journal of Advanced Research (2022) Vol. 52, pp. 3-18
Open Access | Times Cited: 60
p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets
Md. Ataur Rahman, Moon Nyeo Park, MD. Hasanur Rahman, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 53
Md. Ataur Rahman, Moon Nyeo Park, MD. Hasanur Rahman, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 53
It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
Che-Pei Kung, Jason D. Weber
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 45
Che-Pei Kung, Jason D. Weber
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 45
Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest
Jason Rodencal, Nathan G. Kim, Andrew He, et al.
Cell chemical biology (2023) Vol. 31, Iss. 2, pp. 234-248.e13
Closed Access | Times Cited: 34
Jason Rodencal, Nathan G. Kim, Andrew He, et al.
Cell chemical biology (2023) Vol. 31, Iss. 2, pp. 234-248.e13
Closed Access | Times Cited: 34
Cellular senescence: a double-edged sword in cancer therapy
Shuai Xiao, Dongmin Qin, Xueyang Hou, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 32
Shuai Xiao, Dongmin Qin, Xueyang Hou, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 32
Pharmacological reactivation of p53 in the era of precision anticancer medicine
Amos Tuval, Charlotte Strandgren, Angelos Heldin, et al.
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 2, pp. 106-120
Closed Access | Times Cited: 32
Amos Tuval, Charlotte Strandgren, Angelos Heldin, et al.
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 2, pp. 106-120
Closed Access | Times Cited: 32
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
Jinze Shen, Qurui Wang, Yunan Mao, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 24
Jinze Shen, Qurui Wang, Yunan Mao, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 24
Pioneering the future of cancer therapy: Deciphering the p53-ferroptosis nexus for precision medicine
Daiha Shin, Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2024) Vol. 585, pp. 216645-216645
Closed Access | Times Cited: 10
Daiha Shin, Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2024) Vol. 585, pp. 216645-216645
Closed Access | Times Cited: 10
Adipocyte p53 coordinates the response to intermittent fasting by regulating adipose tissue immune cell landscape
Isabel Reinisch, Helene Michenthaler, Alba Sulaj, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Isabel Reinisch, Helene Michenthaler, Alba Sulaj, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control?
Ana Janic, Etna Abad, Ivano Amelio
Cell Death and Differentiation (2024)
Open Access | Times Cited: 8
Ana Janic, Etna Abad, Ivano Amelio
Cell Death and Differentiation (2024)
Open Access | Times Cited: 8
A promising future of metal‐N‐heterocyclic carbene complexes in medicinal chemistry: The emerging bioorganometallic antitumor agents
Qian Zhao, Bo Han, Cheng Peng, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2194-2235
Closed Access | Times Cited: 8
Qian Zhao, Bo Han, Cheng Peng, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2194-2235
Closed Access | Times Cited: 8
The positive feedback loop of the NAT10/Mybbp1a/p53 axis promotes cardiomyocyte ferroptosis to exacerbate cardiac I/R injury
Zhezhe Qu, Xiaochen Pang, Zhongting Mei, et al.
Redox Biology (2024) Vol. 72, pp. 103145-103145
Open Access | Times Cited: 7
Zhezhe Qu, Xiaochen Pang, Zhongting Mei, et al.
Redox Biology (2024) Vol. 72, pp. 103145-103145
Open Access | Times Cited: 7
Cell death pathways: molecular mechanisms and therapeutic targets for cancer
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 7
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 7
Low‐Dose Colchicine Ameliorates Doxorubicin Cardiotoxicity Via Promoting Autolysosome Degradation
Ying Peng, Zhonggen Li, Jianchao Zhang, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 9
Open Access | Times Cited: 6
Ying Peng, Zhonggen Li, Jianchao Zhang, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 9
Open Access | Times Cited: 6
MAPK Signaling‐Mediated RFNG Phosphorylation and Nuclear Translocation Restrain Oxaliplatin‐Induced Apoptosis and Ferroptosis
Yuqin Di, Xiang Zhang, Xiangqiong Wen, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 6
Yuqin Di, Xiang Zhang, Xiangqiong Wen, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 6